Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gudrun Koehl

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Biology International|May 7, 2002
Myosin II redistribution during rear retraction and the role of filament assembly and disassemblyGudrun Koehl, James G McNally
Clinical Hemorheology and Microcirculation|June 10, 2017
Do cell based tissue engineering products for meniscus regeneration influence vascularization?Matthias Koch, Tobias Ehrenreich, Gudrun Koehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude miceMaksim V Yezhelyev, Gudrun Koehl, Markus Guba, et al.
Journal of the American Society of Nephrology : JASN|February 21, 2012
Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney diseaseZlata Novalic, Annemieke M van der Wal, Wouter N Leonhard, et al.
Nature Medicine|February 1, 2002
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorMarkus Guba, Philipp von Breitenbuch, Markus Steinbauer, et al.
The Journal of Biological Chemistry|August 31, 2018
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolismMaša Ždralević, Almut Brand, Lorenza Di Ianni, et al.
Cell Reports|October 3, 2019
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Christina Bruss, Annette Schnell, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Biology International|May 7, 2002
Myosin II redistribution during rear retraction and the role of filament assembly and disassemblyGudrun Koehl, James G McNally
Clinical Hemorheology and Microcirculation|June 10, 2017
Do cell based tissue engineering products for meniscus regeneration influence vascularization?Matthias Koch, Tobias Ehrenreich, Gudrun Koehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude miceMaksim V Yezhelyev, Gudrun Koehl, Markus Guba, et al.
Journal of the American Society of Nephrology : JASN|February 21, 2012
Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney diseaseZlata Novalic, Annemieke M van der Wal, Wouter N Leonhard, et al.
Nature Medicine|February 1, 2002
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorMarkus Guba, Philipp von Breitenbuch, Markus Steinbauer, et al.
The Journal of Biological Chemistry|August 31, 2018
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolismMaša Ždralević, Almut Brand, Lorenza Di Ianni, et al.
Cell Reports|October 3, 2019
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Christina Bruss, Annette Schnell, et al.
Pageof 1